Search details
1.
Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection.
Appl Microbiol Biotechnol
; 104(9): 3971-3979, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32157423
2.
Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
BMC Infect Dis
; 18(1): 500, 2018 Oct 03.
Article
in English
| MEDLINE | ID: mdl-30285653
3.
Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani.
Front Immunol
; 9: 2420, 2018.
Article
in English
| MEDLINE | ID: mdl-30386348
4.
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment.
PLoS One
; 12(9): e0185606, 2017.
Article
in English
| MEDLINE | ID: mdl-28957391
5.
A defined subunit vaccine that protects against vector-borne visceral leishmaniasis.
NPJ Vaccines
; 2: 23, 2017.
Article
in English
| MEDLINE | ID: mdl-29263878
6.
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis.
Vaccine
; 34(25): 2779-86, 2016 05 27.
Article
in English
| MEDLINE | ID: mdl-27142329
7.
KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.
Clin Vaccine Immunol
; 18(7): 1118-24, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21632891
Results
1 -
7
de 7
1
Next >
>>